Lundy Campbell MD

• Professor, Department of Anesthesiology and Perioperative Medicine, University of California San Francisco, School of Medicine, San Francisco

https://anesthesia.ucsf.edu/people/lundy-campbell

The two vein halves were then end-to-end anastomosed and just before finalizing flushed by removing both temporal clips blood pressure 50 over 0 exforge 80mg without a prescription. As no temporal occlusion of any of the vessels is necessary arrhythmia ecg buy exforge on line, we prefer to construct this type of bypass blood pressure top number high buy exforge 80 mg with amex. Distal conventional anastomoses were made on the M2 (n ¼ 4) and on the M3 (n ¼ 10) blood pressure medication cough order exforge 80mg mastercard. This type of flow replacement bypass was described previously in the treatment of internal carotid aneurysms blood pressure medication irbesartan buy discount exforge 80 mg on-line. In the early phases of our experience, for safety reasons we decided to construct the bypass first and planned the definitive aneurysm endovascular treatment 1 or 2 days postoperatively. However, as we found out, the risks of this strategy are twofold-thrombosis of the bypass and postoperative preendovascular treatment aneurysm bleeding-so our present strategy is total exclusion of the aneurysm from the circulation during the same procedure. We succeeded in this in only 11 patients (44%), because in most cases total trapping can be impossible if the complexity of the aneurysm base. In two of these patients, there was still a considerable flow in the aneurysm after distal partial trapping. These remnants, including the parent vessel, were successfully coiled after surgery. However, partial trapping in which the aneurysm itself partially filling also comes with a risk of bleeding of the aneurysm. At that time in the early phase of our experience we decided to plan the definite endovascular treatment 1 day after surgery using detachable balloon as described previously. Surprisingly, the next day, the aneurysm spontaneously thrombosed with the bypass still open. Currently, this is not our strategy, as we consider the risk of thrombosis of the bypass with the parent artery still open too high. We decided not to perform a second bypass procedure because of the relatively small neurological deficits (right-hand paresis), which was probably attributable to a large intracerebral and leptomeningeal collateral network also visible on angiography. In the other two patients, an ischemic region was observed at the site of the temporarily occluded recipient distal M2 and M3 branch. This turned the procedure from a nonocclusive one into a temporal ischemic procedure and it took us 12 minutes to finish the bypass and remove the temporary clips on the bypass. Although the occlusion time was only 12 minutes, which is much shorter than the occlusion time usually necessary for a conventional anastomosis on larger proximal arteries, the patient woke up with right-sided hemiparesis and mild dysphasia. The family refused a postmortem study, but the patency of the bypass of this patient was angiographically confirmed 2 weeks before death. The bypass could then function as a slowly fading, nonphysiologic bridge to reach a new physiologic situation with the aid of leptomeningeal and intracerebral collaterals. It is noteworthy that, in 14 patients in whom the aneurysm was not completely trapped intraoperatively, four aneurysms bled postoperatively (29%). For one patient the bleeding was fatal and in one patient the bypass occluded as the result of this. On the other hand, in 11 patients where complete trapping was possible the minor ischemic complications attributable to trapping or manipulation of the aneurysm did not cause any decrease in long-term functional outcome. The only bypass that on long term occluded after trapping also did not cause any decrease in functional outcome. Retrospectively, this bypass was probably not needed because of the preexisting large collateral flow through intracerebral and leptomeningeal collaterals, as shown on imaging. These differences in the groups with and without direct total trapping suggest that direct total trapping of the aneurysm after bypass construction during the same procedure should be pursued whenever possible. Prevention of hemorrhagic complications probably outweighs the functional decrease caused by ischemic complications. Although numbers are too small to make reliable comparison possible, it is remarkable that three bypasses occluded because of thrombosis at the site of the conventional anastomoses, and another two patients had an ischemic complication with neurological sequelae owing to temporary occlusion time, which was necessary to construct a peripheral conventional anastomosis. This clearly shows that temporary occlusion of arteries to the brain is accompanied by higher risks. The phenomenon of the long-term bypass occlusion in two patients with extensive leptomeningeal collaterals with previous successful and patent bypasses reveals that the human cerebral vasculature is dynamic and that it can adapt itself to changing circumstances. Intraoperative flow measurements on the A2 showed a flow of 30 cc/min to be replaced. According to intraoperative flow measurements, initial flow in the bypass with the A1 still open was 15 cc/min but went up to 30 after trapping the aneurysm, including the A1-A2 segment, demonstrating that the bypass functioned as a 100% replacement bypass. This is because of the large size of the aneurysm and the little space there is left for the thrombosing and consequently swelling aneurysm. In addition, thrombosing perforators coming out of the aneurysm often cause devastating infarcts in the brainstem with consequent sequelae. Finally, complete trapping is seldom possible, leaving the risk of bleeding of the aneurysm. The aneurysm slowly thrombosed, but the next day a progressive brainstem ischemia developed with the bypass still patent and the patient died. Postoperative angiography showed partly thrombosis of the aneurysm due to reversal of flow. After construction of the bypass, the surgeon is able to temporarily occlude the parent artery for a prolonged time for extensive reconstruction of the vascular tree, as the bypass temporarily takes over blood flow. Also, in the case of aneurysm rupture, the neurosurgeon is in complete control; eventually, after several attempts at reconstruction, the decision to permanently trap the aneurysm can easily be made. Of this total, 32 bypasses were patent during further treatment of the aneurysm and 1 was reconstructed in a second procedure. In four patients (12%), the protective bypass turned out to be necessary as a permanent replacement bypass. In two patients (6%), ischemic complications located distally from the aneurysm occurred even without temporal occlusion of the parent artery, suggesting possible embolic sequelae from aneurysm manipulation. C In 29 patients (88%), the functional outcome was favorable (mRs at follow-up < mRs preoperative) at long-term follow-up (mean, 6. To date, endovascular treatment options are still disappointing, and neurosurgical treatment results are by far the most promising. There is no doubt that bypass surgery should be part of the armamentarium of the vascular neurosurgeon who treats these lesions. Therefore, we recommend that patients with these life-threatening lesions be referred to major highly specialized vascular neurosurgical centers where complete and multidisciplinary treatment options are available. Amin-Hanjani S, Du X, Mlinarevich N, et al: the cut flow index: an intraoperative predictor of the success of extracranial-intracranial bypass for occlusive cerebrovascular disease, Neurosurgery 56(Suppl 1):75­85, 2005. Raabe A, Beck J, Gerlach R, et al: Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow, Neurosurgery 52:132­139, 2003; discussion 139. Approximately two thirds are in the anterior circulation and one-third in the posterior circulation. Fusiform aneurysms are thought to arise from atherosclerotic degeneration of the vessel wall that leads to aneurysmal defects in the parent vessel. They often involve entire segments of a first- or second-order intracranial vessel and incorporate branches and perforators. In the endovascular group, the chances of poor outcomes were 12% to 15% in the anterior circulation and 40% in the posterior circulation. In giant aneurysms, a high-risk natural history is associated with a higher treatment risk. Reconstructive techniques include direct clipping of the aneurysm neck and aneurysmorrhaphy (reconstruction of the vessel using redundant aneurysm sac or graft material). Deconstructive techniques include proximal (Hunterian) ligation and trapping of the aneurysmal segment with or without bypass. Clipping of the aneurysm neck is generally seen as the best treatment strategy if it is feasible. Drake6 observed a group of 31 patients with untreatable intracranial aneurysms and found a mortality rate of 66% at 2 years and >80% at 5 years. Most surgical series report an operative mortality of at least 6% and a major morbidity of at least 20%. The results of endovascular therapies should always be compared to these surgical series. Currently, the most common factor for choosing endovascular therapy is anticipated surgical morbidity. Decision making should be done after careful discussions at an experienced center with a multidisciplinary team including microvascular surgeons, endovascular surgeons, anesthetists, and critical care specialists who specialize in treating intracranial aneurysms. Combination surgical and endovascular procedures planned on a collaborative basis have also been reported on an individual basis. The performance of a six-vessel 3-D diagnostic cerebral angiogram is crucial before final decisions about treatment options are made. Catheter-based angiography provides critical information regarding not only the anatomic and morphologic features of the lesion but also the potential for collateral circulation should vessel occlusion be entertained as a treatment option. Multiple angiographic projections or 3-D angiography can be extremely useful at delineating the relevant pathological anatomy. Balloon test occlusion is performed concurrently if permanent vessel occlusion (endovascular or surgical) is considered as a treatment option or as a bailout maneuver. Currently, microsurgical and endovascular deconstructive strategies without a bypass are used only for bailout when other treatment options are not available; this is because all the tests for collateral supply after temporary occlusion have false-negative results and a 16% to 20% chance of an ischemic event exists after carotid sacrifice, even if balloon occlusion tests were negative. The relative importance of surgery and endovascular strategies and their relative merits in terms of safety, effectiveness, ease of use, and durability are being studied. These techniques can be combined in certain situations to augment the advantages and nullify the disadvantages of either modality. Training of aneurysm specialists in both endovascular and microsurgical techniques would stimulate strategies involving both these modalities in a complementary fashion with an aim to decrease overall morbidity and mortality. Endovascular Techniques Endovascular techniques can be generally divided into reconstructive and deconstructive techniques. The technique is quick, noninvasive, and can aid in decision making (surgical versus endovascular versus combination therapy) in acute emergencies, such as when dealing with a concomitant hemorrhage that is producing significant mass effect. However, this technique is dependent on the quality of 3-D image reconstruction; and suboptimal imaging quality can lead to misinterpretation, especially when the aneurysm is intimately associated with bony structures or multiple surgical clips or coils. All patients with a stent or flow-diversion device are placed on clopidogrel (75 mg daily) for 3 months and aspirin (325 mg daily) for life. In these patients, we typically administer a 25- to 35-unit/kg bolus of heparin after the first coil is placed successfully, followed by a similar bolus after intra-aneurysmal flow is reduced. The effect of the heparin is allowed to wear off after the procedure, unless there is evidence of intraprocedural wire perforation or contrast extravasation, in which case the heparin is reversed during or after the procedure with protamine sulfate. Because of the degree of systemic anticoagulation, the arterial access site is typically secured by use of a closure device at the conclusion of the procedure. Before the procedure, preferably the previous day, the patient should be assessed and all the available imaging studies reviewed in preparation for the case. Decisions about overall strategy should be made ahead of time to permit accurate device selection and smooth and efficient performance during the case. Avoidance of general anesthesia also reduces the cardiovascular risk of the overall procedure. Not all patients are candidates for conscious sedation because of poor neurologic status, young age, excessive anxiety, or inability to lie still. General anesthesia offers the advantages of control of the airway as well as reduction or elimination of patient movement during the procedure. Those undergoing stenting on a more urgent basis receive aspirin (650 mg by mouth) and clopidogrel (600 mg by mouth) 4 hours before the procedure. Eptifibatide (2 mg/ kg/min) is continued as an intravenous drip for 4 hours after the procedure to allow the clopidogrel to reach therapeutic levels of platelet inhibition. Brachial or radial artery access may be considered if there is a disease in the iliofemoral arterial segments or descending aorta. Patients with giant aneurysms have a greater likelihood of having an atherosclerotic arch or tortuous and elongated supra-aortic vessel, especially in cases with associated collagenopathies. Additional coils are deployed as necessary to achieve tight packing of several centimeters of the vessel. The two guide catheters previously used most often were the EnvoyW (Codman and Shurtleff, Inc. The guide catheter can be placed directly or by use of an exchange method in patients with tortuous anatomy, atherosclerosis, or fibromuscular dysplasia. We often use a "tower of power" where the Neuron is placed through a large guide catheter for added stability and distal access. Complete stasis of flow can be achieved more quickly with balloons than with coils, but the balloons require a little more preparation. Occlusion of an artery with detachable balloons should always be undertaken with two balloons, placed end to end, with the proximal balloon functioning as a "safety" balloon to minimize the chance of distal migration of the balloons. A balloon size is chosen that is slightly larger than the diameter of the vessel to be occluded. If the guide catheter is large enough, it is preferable to advance the two balloons simultaneously through the guide catheter and into the vessel in order to limit the risk of premature detachment. Ideally, the balloons should be positioned in a relatively straight segment of the vessel. If they are properly sized, they will flatten out and elongate as they are inflated. When the balloon position and stability appear to be satisfactory, the distal balloon is detached by slowly, gently pulling back on the balloon catheter. In general, the vessel should be occluded either at or immediately proximal to the lesion. Vessel occlusion can be accomplished with detachable coils or detachable balloons. Although detachable balloons are not commercially available in the United States at the present time, they are available in Europe and Japan. A single 6-F, 90-cm sheath has an inner diameter large enough to accommodate two microcatheters.

Overall medical condition Fundamentally hypertension quality of life best exforge 80 mg, the suspected etiology of the aneurysm is based on history blood pressure chart when pregnancy cheap exforge 80 mg visa, exam high blood pressure medication and sperm quality buy genuine exforge, and imaging blood pressure diastolic low exforge 80mg order with visa. Based on imaging exforge blood pressure medication 80 mg exforge buy mastercard, the size and location of the aneurysm must be considered along with any other potential neuroanatomic considerations. In addition, an important factor for determining appropriate treatment to minimize morbidity is the identification of significant perforators, which may emanate from the aneurysm itself and may not be fully recognized until intraoperatively. Treatment strategies for fusiform M1 aneurysms may be based (in part) on the involvement of perforators. Intraoperative angiography can be helpful in determining the optimal configuration of flow remodeling. Acute traumatic arterial dissection involving a focal M1 segment is rare, but if the resulting fusiform aneurysm with dissected flap demonstrates significant flow limitation, associated pseudoaneurysm, or rupture in a patient whose overall medical condition would tolerate invasive therapies, options include surgical trapping with bypass, endovascular takedown with bypass, or endovascular reconstruction. The patient was a highly functional 67-year-old male with work-up for near-syncopal episode, treated conservatively with anti-platelet agents. The surgical option of simply clipping the neck of the aneurysm and preserving the direct flow from the M1 trunk to the M2 branches may be precluded by calcified atheromatous base, thick walls with giant wide neck, extensive thrombosis, or anatomic configuration of the M2 origins. Booster clips or a complex combination of clips may be required to achieve clipping of giant aneurysms, and the use of a vascular clamp for assistance has also been described. Post-operative complications may include graft thrombosis, anastomotic leak, pseudoaneurysm, and ischemic or thromboembolic stroke. As previously mentioned, distal infectious aneurysms are often associated with infective endocarditis and cardiac valvular disease, which should optimally be co-managed with infectious disease and cardiac specialists. The natural history of infectious intracranial aneurysms is not fully understood, although there appears to be a relatively high risk of rupture confounded by the fact that cerebrovascular imaging tends to be done for patients who are symptomatic and have high pre-test probability of mycotic aneurysms and septic emboli. When infectious cerebral aneurysms are noted in coexistence with severe cardiac valvular disease, it may be challenging to determine the optimum timing of whether treatment of the aneurysm versus cardiac valve repair should be undertaken first. Patients in moribund condition may also be considered for conservative treatment regardless of aneurysmal configuration. If the patient is in reasonable overall medical condition, surgical or endovascular trapping may be considered regardless of the size or rupture status of the infectious aneurysm. If the aneurysmal configuration is amenable, direct surgical clipping may even be feasible as a preferred option, but more commonly the configuration requires proximal and distal trapping with possible excision of the infectious aneurysm. Positioning the patient is usually positioned in the conventional position for a pterional craniotomy with the head turned toward the contralateral side fixed in a three-point Mayfield holder with the temporal bone parallel to the floor; ipsilateral shoulder rolls may be placed if necessary. Preparation of the Donor Graft Portable Doppler ultrasound is used to map the location and course of donor vessels. Vasoconstrictive agents such as epinephrine should not be used in local infiltration. The temporalis muscle is divided and retracted, then a standard pterional bone flap is removed, the dural is opened in a U-shaped fashion with the dura remaining attached toward the base of the Sylvian fissure, and dissection of the arachnoid layer is performed to expose an approximately 1-cm segment of recipient vessel. A rubber dam is placed as background to facilitate anastomosis, and flowprobe monitoring is performed to obtain baseline flow measurements on the donor and recipient vessels. Surgicel is used to line the anastomosis, temporary clips are released, and flow probe is used to check flow in the components of the anastomosis. Intraoperative monitoring with electroencephalography and evoked potentials may optionally be used. Flow-probe monitoring may be used after bypass to assess flow,37 and intraoperative cerebral angiography may be used to assess bypass patency and hemodynamic configuration. He reportedly had distant history of Staphylococcus aureus bacteremia with seeding of the mitral valve at age 17 with source unclear and denied any history of intravenous drug use. His past medical history was otherwise only notable for L4-L5 discectomy and laminectomy with posterior spinal fusion (L4-L5 pedicle screws and rods) and transforaminal lumbar interbody fusion 3 years prior followed by removal of segmental spinal instrumentation 2 years prior after bony fusion (for low back pain and left hip pain since resolved) for which he had been off construction work for the past 4 years. The artery was dissected along its length from the superior border of the zygoma to its distal end at the right parietal region. Four burr holes were placed around the planned craniotomy with curettes used to remove the inner table, and a #3 Penfield dissector was used to separate the dura from the inner surface of the skull. The craniotome was used to connect the burr holes into a rectangular-shaped bone flap, which was then removed. Clamps were released with one leak site at the anastomosis noted for which the clamps were reapplied with one additional suture placed at the leak site. The back wall of the anastomosis is sutured first (I) followed by the front wall of the graft (J). A J-shaped aneurysm clip was then placed on the afferent vessel entering the aneurysm for proximal occlusion, and then intraoperative focused cerebral angiography was performed. At the Y-shaped junction, it was known that there was a second efferent vessel adjacent to the vessel that received bypass, which were both in close proximity to the aneurysm. Attempts for distal occlusion of the aneurysm would force the clip onto the branch vessels, and the alternative of opening the aneurysm and cleaning out the edge to place the clip without compromising the branch vessels was felt to be a higher potential risk than benefit given that the intraoperative angiography showed that the aneurysm was no longer filling with the current operative configuration. If the intraoperative angiography had shown continued filling of the aneurysm, then distal occlusion would have been pursued by placing temporary distal clips and opening the aneurysm to clean out the edge to allow the aneurysm clip to sit securely on the distal site. The patient remained neurologically intact immediately after surgery and at his 5-month follow-up visit. Early compromise of the bypass graft may be surgically re-explored with thrombectomy or re-anastomosis, intraoperative prophylactic mechanical or topical medication techniques may be used for minimizing vasospasm, endovascular therapies may be attempted for delayed vasospasm, and consideration of new therapeutic approaches need to be devised if pseudoaneurysms involving the bypass graft or recurrence of aneurysm occurs at follow-up. Lenticulostriate perforators emerging from the proximal and distal back walls of the aneurysm were identified intraoperatively. Intraoperative photograph demonstrates the fusiform right M2 infectious aneurysm with retractors and microsuction in the field (D), and gross pathology specimen photograph of the excised aneurysm is shown (E). Chen L, Kato Y, Sano H, et al: Management of complex, surgically intractable intracranial aneurysms: the option for intentional reconstruction of aneurysm neck followed by endovascular coiling, Cerebrovasc Dis 23:381­387, 2007. Karnchanapandh K, Imizu M, Kato Y, et al: Successful obliteration of a ruptured partially thrombosed giant m1 fusiform aneurysm with coil embolization at distal m1 after extracranial-intracranial bypass, Minim Invasive Neurosurg 45:245­250, 2002. Nakatomi H, Segawa H, Kurata A, et al: Clinicopathological study of intracranial fusiform and dolichoectatic aneurysms, Stroke 31:896, 2000. Takeo G, Kenji O, Akimasa N, et al: Treatment of a fusiform middle cerebral artery aneurysm at M1 part which cause cerebral infarction at its perforating area: a case report, Surg Cerebral Stroke 34:59­63, 2006. Ferroli P, Ciceri E, Parati E, et al: Obliteration of a giant fusiform carotid terminus-M1 aneurysm after distal clip application and extracranialintracranial bypass. Lubicz B, Collignon L, Lefranc F, et al: Circumferential and fusiform intracranial aneurysms: reconstructive endovascular treatment with self-expandable stents, Neuroradiology 50:499­507, 2008. Navratil O, Lehecka M, Lehto H, et al: Vascular clamp-assisted clipping of thick-walled giant aneurysms, Neurosurgery 64:113­120, 2009. Ceylan S, Karakus A, Duru S, et al: Reconstruction of the middle cerebral artery after excision of a giant fusiform aneurysm, Neurosurg Rev 21:189­193, 1998. Tsutsumida H, Nakamura K, Matsuzaki Y, et al: A case of heart operation in infective endocarditis after brain surgery for mycotic cerebral aneurysm, Kyobu Geka 53:229­232, 2000. Uchino T, Hirayama T, Ishikawa M, et al: A case report of early valve replacement surgery in infective endocarditis with mycotic cerebral aneurysm, Nippon Kyobu Geka Gakkai Zasshi 37:2025­2028, 1989. Shiraishi Y, Awazu A, Harada T, et al: Valve replacement in a patient with infective endocarditis and ruptured mycotic cerebral aneurysm, Nippon Kyobu Geka Gakkai Zasshi 40:118­123, 1992. Kuki S, Yoshida K, Suzuki K, et al: Successful surgical management for multiple cerebral mycotic aneurysms involving both carotid and vertebrobasilar systems in active infective endocarditis, Eur J Cardiothorac Surg 8:508­510, 1994. Scamoni C, Dario A, Castelli P, et al: Extracranial-intracranial bypass for giant aneurysms and complex vascular lesions: a clinical series of 10 patients, J Neurosurg Sci 52:1­9, 2008. Cantore G, Santoro A, Guidetti G, et al: Surgical treatment of giant intracranial aneurysms: current viewpoint, Neurosurgery 63:279­289, 2008. Lower basilar aneurysms affect the inferior basilar trunk and the vertebrobasilar junction. Anatomic variability of the vertebrobasilar tree and its branches in relationship to the surrounding anatomy and the configuration, size, and orientation of the aneurysms in this region preclude the universal application of a single operative approach. Each case requires consideration of the particular features of the lesion and selection of an approach that provides the necessary surgical corridor. Endovascular treatments have become increasingly important in the management of these difficult aneurysms, but this chapter focuses on surgical management. Numerous perforators arise along the entire course of the posterior and lateral surfaces of the basilar artery, but not along its anterior surface. The perforators supply cranial nerve nuclei, reticular centers, and input-output pathways for the cerebrum and cerebellum. Along the midbasilar portion, the long lateral pontine arteries exit and course laterally to supply the paramedian and lateral pons. Intraparenchymal bleeding, which can be associated with anterior circulation aneurysms, is rarely a feature of these aneurysms. As with other posterior circulation aneurysms, the natural history of these aneurysms appears to be that of high rupture rates. Fusiform and dissecting aneurysms are more common in the posterior circulation than in the anterior circulation and are associated with a poor prognosis. The vertebrobasilar junction is typically located near the midline of the clivus at the level of the pontomedullary junction. Numerous perforating branches, in addition to the larger main branches, exit along its course. These lesions are particularly challenging and often require indirect approaches for their obliteration compared to the standard direct clipping techniques most often used for saccular aneurysms. Patients with neurological symptoms related to the mass effect of an aneurysm are managed semi-urgently. These patients typically exhibit signs of brainstem compression or cranial nerve deficits, which must be considered when planning both the surgical approach and timing of surgery. In fact, intraoperative blood pressure is allowed to run mildly hypertensive, especially during temporary vessel clipping. For brain protection, all patients receive intravenous doses of barbiturates (pentobarbital) to achieve electroencephalographic burst suppression. Depending on the specific anatomy and configuration of the aneurysm, the following approaches can be appropriate. Moving from superior to inferior, the following approaches provide overlapping access to the mid- and lower-basilar artery: subtemporal, extended orbitozygomatic approach, transpetrosal approach, lateral suboccipital-retrosigmoid, and far-lateral. Combinations of these approaches (combined supra- and infratentorial approach and combined-combined) can extend exposure as sometimes needed for large aneurysms. Typically, the subtemporal and orbitozygomatic approaches are used for basilar tip lesions, but the extended orbitozygomatic approach can provide access to the upper two-fifths of the basilar artery. The transpetrosal provides exposure further inferiorly, allowing the middle three-fifths of the basilar trunk to be accessed. With the combined supraand infratentorial approach, access can be extended down to the vertebrobasilar junction. The far-lateral approach gives access primarily to the lower two-fifths of the basilar artery and is suitable for vertebrobasilar junction aneurysms. Regardless, the primary endpoint for the surgeon should be complete obliteration of the aneurysm from the circulation, with preservation of the parent vessels, particularly the perforators supplying the brainstem. To achieve optimal aneurysm obliteration, maximal exposure of the basilar artery and the aneurysm itself is required. This exposure must be achieved without exposing the brain or critical structures to undue retraction while simultaneously obtaining adequate control of the parent vessel and aneurysm. Given the challenges of exposure in this region, specialized operative approaches are often necessary. In contrast, however, the transpetrosal approach exposes the aneurysm sac between the surgeon and the neck. There is still a role for the standard subtemporal craniotomy and lateral suboccipital/retrosigmoid craniotomy in approaching the upper-mid and mid-lower basilar artery, respectively, especially given that the more extensive approaches such as radical petrosectomy are associated with inherent morbidity. These standard craniotomies can be used for small, favorably located, unruptured aneurysms. For larger aneurysms, however, the routine lateral suboccipital or retrosigmoid approach may not adequately expose the mid- or lower-basilar trunk without an unacceptable amount of cerebellar or brainstem retraction. For aneurysms involving the basilar trunk above the vertebral bifurcation, the transpetrosal approaches increase rostral exposure for distal control and decrease the operative distance to the lesion. Even the extent of this exposure, especially for larger aneurysms, can be limited, leading to the utility of the combined approaches. The combined supra- and infratentorial approach with its appropriate variations permits exquisite surgical exposure for dealing with most aneurysms involving the mid- and lower-basilar artery. The far-lateral approach, alone or in combination with other approaches, provides excellent access to the lower basilar and vertebrobasilar junction. The basic principles of aneurysm surgery still apply: (1) proximal and distal vascular control, (2) preservation of parent vessels and all perforators, and (3) complete obliteration of the aneurysm. In the past, these aneurysms were treated through a subtemporal-transtentorial approach or through the suboccipital approach. Although these approaches can provide access to aneurysms of the mid- and lower-basilar artery, they seldom provide maximal exposure with minimal retraction. The basic tenets of these approaches and their application to mid- and lower-basilar artery aneurysms are reviewed. Orbitozygomatic Subtemporal Extended Orbitozygomatic Approach the standard orbitozygomatic craniotomy, which has been well described for the management of tumors and aneurysms of the upper basilar artery,14,24­27 can be modified to allow access to the upper aspect of the midbasilar trunk. Far-lateral and extended orbitozygomatic approaches provide a view along the neck of the aneurysm, allowing a clip to be applied along this line of sight. The transpetrosal approach exposes the aneurysmal sac between the surgeon and the neck, necessitating a right-angle clip. The translabyrinthine approach removes more of the petrous bone (including the semicircular canals, thereby increasing exposure anteriorly to the internal auditory canal), and sacrifices hearing. The transcochlear approach involves maximal petrous bony resection by transposing the facial nerve posteriorly and allowing access for removal of the cochlea. In each variation the amount of petrous bone resection increases with a resultant increase in exposure of the anterior brainstem and basilar trunk.

Buy generic exforge 80 mg line. Digital Full Automatic Upper Arm Blood Pressure Monitor Health Monitors sphygmomanometer.

These limitations to the oral route translate into an increased variability in patient response (Table 2-1) 01 heart attack mp3 order 80mg exforge free shipping. The absorption of aspirin is promoted by ion trapping within the plasma; the low pH of stomach fluid favors gastric retention of codeine arrhythmia nodosum discount exforge online american express. For weak electrolytes blood pressure vitamin d order discount exforge, the pH of the surrounding medium affects the degree of ionization and drug absorption blood pressure medication heart rate discount 80 mg exforge visa. Because the H+ concentrations of the stomach and small intestine diverge widely blood pressure empty chart exforge 80mg order, the two structures seem to be qualitatively dissimilar in their respective patterns of drug absorption. Aspirin is an organic acid with a pKa (negative log of the dissociation constant) of 3. In gastric juice (pH 1 to 3), aspirin remains largely nonionized, and its passage across the stomach mucosa and into the bloodstream is favored. When equilibrium is established, the concentration of nonionized aspirin molecules on both sides of the membrane is the same, but the total amount of drug (ionized plus neutral forms) is much greater on the plasma side. The biologic process that sustains this partitioning is the energy-consuming secretion of H+ by the gastric parietal cells. A mixed meal of solids and liquids usually begins to enter the duodenum in about 30 minutes and requires about 4 hours to leave the stomach completely. Conversely, a glass of water ingested on an empty stomach is moved into the small intestine in a more rapid fashion, with half of the water expelled from the stomach in 15 minutes, and essentially all of the liquid removed by 1 hour. Normally, most oral medications should be taken in the absence of food but with a full glass of water. This procedure speeds drug entry into the small intestine and provides maximum access to the gastrointestinal mucosa. Occasionally, the presence of a fatty meal promotes the absorption of a drug that has a high lipid but low water solubility. The protease inhibitor saquinavir and the fat-soluble vitamins are examples of substances that are better absorbed in the presence of lipids. In these instances, the delay in gastric emptying produced by the high fat content of the chyme is compensated for by a more complete absorption. Because gastric emptying is often a limiting factor in the rate of drug absorption, many unrelated drugs exhibit latency periods (the lag phase between oral ingestion and onset of drug effect) of a similar magnitude. Codeine is almost completely ionized in the acidic environment of the stomach; absorption is negligible, and virtually all the drug remains within the stomach. Even when injected intravenously, they tend to accumulate in the stomach by crossing the gastric mucosa in the reverse direction. Questions of intravenous overdosage can often be answered from the analysis of stomach contents. The pH of the proximal one-fourth of the intestine varies from 3 to 6, but it reaches neutrality in more distal segments. Under these more alkaline conditions, aspirin converts to the anionic form, whereas a significant fraction of the codeine molecules give up their positive charge. Although basic drugs are favored for absorption over acids in the small intestine, ion trapping is not as extensive because the pH differential across the intestinal mucosa is small. Differences in intestinal absorption based on pH are more concerned with the rate of uptake than with its extent. As one might expect, neutralization of gastric contents by the administration of antacids or ingestion of food temporarily removes the qualitative disparity in electrolyte absorption normally observed between the stomach and the small intestine. Influence of dosage form Although the times required for gastric emptying and for diffusion across the mucosal barrier undoubtedly contribute to the delayed onset of action of drugs taken orally, situations exist in which these events are not rate limiting. Most drugs intended for oral use are marketed in the form of capsules or solid tablets. In contrast to solutions, these preparations must first dissolve in the gastrointestinal fluid before absorption can occur. If dissolution is designed to be very slow, it can become the controlling factor in drug absorption. The first step in the dissolution process is the disintegration of the tablet (or the capsule and its granules) to yield the primary drug particles. The dissolution process may be considered rate limiting whenever a drug solution produces a systemic effect faster than a solid formulation of the same agent. Sometimes discrepancies in absorption between dosage forms are of such magnitude that clinical differences are noted. With aspirin, the concentration of drug in the plasma 30 minutes after administration can be twice as high for a solution as for a solid tablet. Although it is unclear whether this difference results solely from drug dissolution or from other factors, such as the more rapid gastric emptying typical of liquids, dissolution is probably at least partially responsible. The influence of dosage form on drug absorption is often taken advantage of by drug manufacturers. To avoid release of certain drugs within the stomach, they are often prepared in the form of enteric-coated tablets. The covering is insoluble under acidic conditions, but it does break down to permit tablet disintegration in the more alkaline environment of the small intestine. Although these preparations are often beneficial, their usefulness nevertheless is negatively affected by an increased variability in patient response. Because drug absorption cannot begin until the tablet passes into the duodenum, the time required for gastric transit becomes an important variable. The passage of a single insoluble tablet from the stomach into the intestine is a random event that can take several minutes to more than 6 hours. Sustained-release preparations represent another method of capitalizing on the influence of formulation on drug absorption. These products are usually designed to release a steady amount of drug Mucosal surface area A second major difference between absorption in the stomach and absorption in the small intestine relates to the intraluminal surface areas involved in drug uptake. Aside from certain mucosal irregularities (rugae), the stomach lining approximates that of a smooth pouch with a thick mucus layer. In contrast, the mucosa of the small intestine is uniquely adapted for absorption. Contributions by the folds of Kerckring, villi, and microvilli combine to increase the effective surface area 600-fold. Assuming a small intestine 280 cm in length and 4 cm in diameter, approximately 200 m2 are available for drug absorption. The surface/volume ratio in the small intestine is so great that drugs ionized even to the extent of 99% may still be effectively absorbed. As a result, although pH considerations favor the gastric absorption of aspirin, as much as 90% of the drug is actually absorbed from the small intestine in vivo. Experimentally, nonelectrolytes such as ethanol are also absorbed from the intestine many times faster than from the stomach. Gastric emptying Because almost any substance that can penetrate the gastrointestinal epithelium is best absorbed in the small intestine, the rate of gastric emptying can significantly affect drug absorption, particularly for organic bases that are not absorbed at all from the stomach. A cyclical pattern of activity occurs in fasting patients where periods of quiescence (about 1 hour each) are followed by contractions that increase in intensity over a 40-minute period before terminating in a short burst of intense contractions that migrate from the stomach to the distal ileum. Ingesting a tablet or small volume of liquid may result in gastric retention of the drug for 1 hour or longer. Some preparations also provide an initial loading dose that is readily available for absorption. Sustained release may be accomplished by using a porous matrix, with the drug located in the interior spaces and on the external surface. An alternative is to make spheres of drug that dissolve at different rates because of various coatings. The sensitivity of gastrointestinal absorption to variations in drug formulation is best exemplified by the concern over bioavailability. In many instances, chemically identical drugs have proved in the past to be biologically nonequivalent because of differences in formulation. In one study of tetracycline hydrochloride, nine preparations from different manufacturers were compared with an aqueous solution of the same drug. Although seven brands produced blood concentrations ranging from 70% to 100% of the reference solution, two products exhibited relative bioavailabilities of only 20% to 30%. Differences in bioavailability are more clinically important with drugs that are poorly absorbed, have low margins of safety, and are inactivated by capacity-limited processes. Bioavailability considerations related to drug selection are considered further in Chapter 42. Binding to constituents of chyme, chelation with divalent cations, or formation of insoluble salts may decrease the amount of drug available for absorption. A special fate exists for substances that are successfully absorbed from the gastrointestinal tract. The venous drainage of the stomach, small intestine, and colon is routed by the hepatic portal system to the liver. A first pass of high drug concentration through this enzymeladen organ can significantly reduce the quantity of agent reaching the systemic circulation. For example, lidocaine is metabolized so rapidly in the liver that virtually all of an oral dose is destroyed during its first pass. Although less pronounced, disparities in opioid analgesic and antibiotic efficacies observed between the oral route and other modes of administration are of clinical importance to the practice of dentistry. Other enteral routes the oral and rectal mucosa are occasionally used as sites of drug absorption. Sublingual administration, in which a tablet or troche is allowed to dissolve completely in the oral cavity, takes advantage of the permeability of the oral epithelium and is the preferred route for a few potent lipophilic drugs, such as nitroglycerin and oxytocin, and even the commonly used oral sedative triazolam. Because gastric acid and intestinal and hepatic enzymes are bypassed, sublingual absorption can be more efficient overall for certain drugs than intestinal uptake. In dentistry, triazolam generally reaches peak effect in 20 to 30 minutes sublingually, as compared to 30 to 45 minutes orally. Rectal administration may be used when other enteral routes are precluded, as in an unconscious or nauseated patient. Although a significant fraction of absorbed drug enters the circulation without having to pass through the liver, uptake is often unpredictable. For many patients, aversion to rectal introduction of drugs prohibits administration by this route. Active transport Most drugs intended for oral use are absorbed by passive diffusion. Active transport systems do exist, however, for specific dietary constituents that sometimes increase the absorption of certain drugs. P-glycoprotein is highly expressed along the luminal surface of intestinal epithelial cells, where it exports xenobiotics that would otherwise be absorbed. This function is in concert with the "chemoimmunity defensive" role P-glycoprotein plays in protecting cells from exposure to potentially toxic compounds. Although P-glycoprotein may delay the absorption of many drugs and prevent altogether the uptake of pharmaceuticals of low absorptive potential, it is probably of minor significance regarding the extent of absorption of most drugs intended for oral use, whose concentrations in the chyme are sufficient to overwhelm the capacity of P-glycoprotein to export them. Inhalation the alveolar membrane is an important route of entry for some drugs and many noxious substances. Although the alveolar lining is highly permeable, it is accessible only to agents that are in a gaseous state or are inhaled in sufficiently fine powders or microdroplets to reach the deepest endings of the respiratory tree. Gaseous agents include the therapeutic gases, carbon monoxide, inhalation anesthetics, and numerous volatile organic solvents. The second category of alveolar membrane penetrants is collectively known as aerosols. This term refers to liquid or solid particles small enough (usually 10 m in diameter) to remain suspended in air for prolonged periods. Any such finely divided material, when inhaled, reaches some portion of the respiratory tree and is affected by the processes of sedimentation and inertial precipitation. Therapeutic use of aerosols is not widespread, but some emergency medications are prepared in this form. Because the onset of effect is extremely rapid after inhalation of an aerosol drug, this route can provide a means of quick self-medication for individuals in danger of acute allergic reactions to venoms or drugs. Many respiratory drugs are also prepared in aerosol form because they are highly effective by this route while minimizing systemic exposure. The rapidity and efficiency of alveolar membrane absorption can occasionally pose problems for therapy, however, as illustrated by the use of aerosols containing isoproterenol. Although 97% of an isoproterenol spray is swallowed under normal conditions and inactivated by various enzymes, Drug inactivation A shortcoming of oral ingestion is the inactivation of drugs before they reach the systemic circulation. Gastric acid is one of the principal causes of drug breakdown within the gastrointestinal tract, but degradation also results from enzymatic activity. Vasopressin, insulin, calcitonin, and other polypeptides are subject to hydrolysis by pancreatic and intestinal peptidases. Enteric bacterial enzymes may also destroy certain ingested agents, such as chlorpromazine. This reflects the hazards of aerosols when abused and provides a caveat for uncontrolled self-medication with any potentially dangerous drug. Concern over aerosols is also related to questions of toxicology, such as the absorption of heavy metal dusts by industrial workers. Intravenous route the administration of drugs by infusion or injection directly into the bloodstream is particularly useful when immediate effects or exact blood concentrations are desired. Also, through the technique of titration, the intravenous route provides an avenue for the controlled administration of drugs that have a very narrow margin of safety between therapeutic and toxic concentrations. The infusion of lidocaine to prevent ventricular arrhythmias and the incremental injection of antianxiety drugs during intravenous sedation are two examples in which titration is used to achieve a desired effect while avoiding adverse reactions. The method of injection selected varies with the particular drug and therapeutic need of the patient (Table 2-1). The outer layer of skin (stratum corneum) is densely packed with the protein keratin.

Methionine deficiency is believed to be associated with degenerative nervous system changes blood pressure medication used for sleep buy generic exforge on line. It has been suggested that preoperative administration of methionine may counteract some of the adverse effects of nitrous oxide on the hematologic and nervous systems blood pressure medication edarbi cheap exforge 80 mg online, and methionine has been used in the treatment of nitrous oxide­ induced neuropathy 2014 purchase 80 mg exforge free shipping. Intermittent exposures have a cumulative effect if spaced more frequently than once every 3 to 4 days heart attack mike d mixshow remix buy exforge online from canada. These findings have limited the use of nitrous oxide as an analgesic agent for extended use and for procedures that must be repeated often blood pressure test buy exforge 80 mg online, such as debridement of burned skin. The inhibition of methionine synthesis by nitrous oxide has been associated with an increased risk of myocardial ischemia in patients undergoing vascular surgery. Patients at special risk include patients with genetic mutations that cause a deficiency in 5,10-methylenetetrahydrofolate reductase activity. This enzyme generates the 5-methyltetrahydrofolate required for methionine synthesis; its deficiency potentiates the pathway block caused by nitrous oxide. This concern, as well as the increased risk of postoperative nausea and vomiting, has prompted many anesthesiologists to abandon the use of nitrous oxide for any patient with known or suspected cardiovascular disease regardless of surgical procedure. Pretreatment with B vitamin supplements for 1 week before anesthesia can prevent the hyperhomocysteinemia believed to cause these adverse effects. More recent studies have not shown a detrimental cardiovascular effect but the use of nitrous oxide for medical surgery has decreased significantly in many parts of the world. There were contradictory data on effects on myocardial infarction, yet no difference in mortality. A well-controlled recent study determined that nitrous oxide had no negative cardiovascular effects for at-risk patients in non-cardiac surgery, did not lead to increased surgical site infection, but did increase the frequency of postoperative nausea and vomiting (see Myles et al. Therefore the evidence does not support the suggestion that nitrous oxide effects are significant on predisposition to cardiovascular complications. Similar to other mood-altering drugs, nitrous oxide may be abused by individuals with access to the drug, including members of the dental profession. This abuse is associated with myeloneuropathic changes indicative of a pernicious anemia­like syndrome: numbness and paresthesia, muscular weakness and incoordination, altered spinal reflexes, impotence, and shooting sensations on flexion of the neck (Lhermitte sign). Nitrous oxide has been shown to inhibit the release of luteinizing hormone­releasing hormone by the hypothalamus, which theoretically may impair fertility. Potential reproductive toxicity has also been proposed to be caused by the sympathomimetic effects of nitrous oxide leading to vasoconstriction and diminished uterine blood flow. Clinical use in pregnant women carries no apparent increased risk to the fetus, however, over other acceptable forms of pain control. Long-term exposure has been strongly implicated in other reproductive abnormalities, such as spontaneous abortion and impaired fertility, but these effects have not been substantiated by controlled prospective studies. Retrospective surveys have provided evidence that operating room personnel (surgeons, anesthesiologists, nurses) and dentists and their employees exposed to nitrous oxide may be adversely affected by trace amounts of inhalation anesthetics. Specifically, exposed health care workers reported a higher incidence of hepatic, renal, and neurologic disorders; increased congenital malformations in children born to exposed women; and increased spontaneous abortions in exposed women and wives of exposed men. Although retrospective studies that used examination of public health registries could find no link between working in an operating room (or being exposed to anesthetic gases) and increased risk of miscarriage or congenital malformation. Reproductive toxicity in dental assistants has been linked to nitrous oxide exposure of more than 3 to 5 hours per week (See Rowland et al. Because many dentists function as sedationist and surgeon, the nonrebreathing flow machine is most commonly used. Its simplicity of operation and compatibility with minimal to moderate sedation is coupled with the major disadvantage of exposing operatory personnel to potentially high concentrations of anesthetic gases. The National Institute for Occupational Safety and Health has prepared a monograph (see reference) to assist dentists in minimizing exposure to nitrous oxide in the workplace. There is the possibility that long-term exposure to trace concentrations of nitrous oxide may be a health hazard to dental office and operating room personnel. An early report of inhaled concentrations of as little as 50 ppm over a 2-hour span causing impairment in audiovisual performance tasks has not been reproduced (see Bruce and Bach, reference). Nevertheless, this finding prompted the National Institute for Occupational Safety and Health to recommend 25 ppm as a maximum permissible time-weighted exposure limit per anesthetic administration for all health care workers. This level may not be achievable with some existing scavenging systems, so other measures. Isoflurane does not significantly sensitize the heart to dysrhythmias; the permissible tissue injected dose of epinephrine during isoflurane anesthesia is at least 7 mcg/kg. Maximum local anesthetic doses would be reached well before this dose of epinephrine in local anesthetic solutions. Therapeutic uses Nitrous oxide is a widely used inhalation anesthetic and continues to play a role in the delivery of medical and dental anesthesia. It is valuable in reducing the concentration of volatile anesthetics during inhalation anesthesia and as a component of "balanced anesthesia. Since the late 1950s, there has been an upsurge in the use of nitrous oxide, not to provide dental surgical anesthesia, but to provide relief from anxiety in the form of minimal to moderate sedation. Conversely, its use for general anesthesia in medicine is declining because of the increasing reliance on intravenous anesthesia coupled with concerns about occupational exposure to the gas and previously reported cardiovascular concerns. Respiratory effects Respiratory depression manifests as a decreased ventilatory response to hypercapnia with a complete loss of sensitivity to hypoxia. Other effects Isoflurane depresses cerebral metabolism and cerebral metabolic requirement for oxygen. Isoflurane causes little change in the cerebrospinal fluid pressure and does not significantly alter cerebrospinal fluid production. Isoflurane After its release in the United States in 1981, isoflurane became the most widely used volatile anesthetic. It is an isomer of enflurane, which was a halogenated methyl ethyl ether introduced into clinical use in the United States in 1972, but since withdrawn from use. Isoflurane combines the desirable cardiovascular properties of enflurane with a freedom from seizure activity and less respiratory depression and hepatic metabolism. Although the newer, less soluble volatile anesthetics are more frequently used in the United States, isoflurane is less expensive and remains a useful anesthetic for many purposes. This finding suggests that it is neither nephrotoxic nor hepatotoxic, a conclusion supported by observations that repeated and prolonged exposures to isoflurane have not caused hepatorenal injury in animals. Although there are a few case reports of hepatic necrosis after isoflurane administration, it is currently believed that isoflurane is highly unlikely to be responsible for postoperative hepatotoxicity. Isoflurane is chemically stable, nonflammable, and marketed in brown glass bottles. Therapeutic uses Isoflurane is a suitable drug whenever a potent inhalation anesthetic is to be administered, except when a mask induction of anesthesia is contemplated. In pediatric patients, induction with isoflurane is more likely to elicit coughing, salivation, and laryngospasm than induction with sevoflurane. These effects can be prevented by prior administration of an intravenous induction agent. Isoflurane has numerous advantages: it is chemically stable, nonflammable, and potent; induction is rapid, and muscle relaxation is adequate; and it is not dysrhythmogenic or toxic to the kidneys or liver. Inhalation induction should theoretically be relatively rapid with isoflurane, but it is limited by its pungent odor, which, if induction is allowed to proceed too rapidly, leads to breath holding, laryngospasm, and coughing. This problem is usually overcome by inducing the patient with an intravenous agent prior to administering isoflurane. Isoflurane is sufficiently potent to provide muscle relaxation adequate for any surgical procedure, but neuromuscular blocking agents are normally used for procedures that require profound muscle relaxation instead of the high concentrations of anesthetic needed to secure muscle relaxation. As with other potent inhalation anesthetics, isoflurane increases the action of the nondepolarizing neuromuscular blocking drugs. Desflurane Desflurane, approved for clinical use in 1992, is the first volatile anesthetic agent whose blood/gas partition coefficient (0. Nevertheless, desflurane is particularly suited for ambulatory anesthesia and is commonly used for other situations in which an inhalation anesthetic is indicated. Also, the increased cost of desflurane is counterbalanced by the faster recovery of the patient. Cardiovascular effects Similar to all volatile anesthetics, isoflurane produces a dose-dependent depression of myocardial contractility, but it is similar to that of desflurane and sevoflurane. Isoflurane also causes coronary vasodilation, mostly at the distal (resistance) arterioles. Although this effect may be beneficial for heart muscle, it was also proposed to cause "coronary steal" in patients with ischemic heart disease, a situation in which blood flow is redistributed from myocardial tissues supplied by atherosclerotic arteries to areas with healthy coronary vessels. Coronary steal develops only when the coronary perfusion pressure is decreased, is more likely to occur with excessive tachycardia, and is most probably not a special concern with isoflurane. Cardiac output is well maintained Physical and chemical properties Desflurane is chemically very similar to isoflurane, with only a single substitution of fluorine for a chlorine atom. Desflurane shows marked chemical stability, possibly because of the additional fluorine, which provides resistance to break down in soda lime and to biotransformation. The low potency and high volatility of desflurane require the use of a heated vaporizer to enable precise delivery of this agent. A propensity to cause breath holding, coughing, and laryngospasm during mask induction precludes its routine use as a primary induction agent. The systemic vascular resistance, mean arterial blood pressure, and stroke volume are reduced, but the cardiac output is maintained by a progressive increase in heart rate. Discernible increases in heart rate occur as the anesthetic concentration exceeds 1. Similar to isoflurane, desflurane theoretically may cause coronary steal in hypotensive cardiac patients. Desflurane causes a dose-related decrease in tidal volume and, despite an increase in the respiratory rate, a significant depression of minute ventilation. As with other halogenated ethers, respiratory depression is reduced if desflurane is used with nitrous oxide for anesthesia. Desflurane is contraindicated in patients susceptible to malignant hyperthermia because it can trigger the syndrome in the swine model and has been linked to malignant hyperthermia in the clinical setting. Because desflurane is notable for having minimal biotransformation, it has a very low likelihood for causing serious hepatotoxicity. However, plasma F- declines much more rapidly with sevoflurane, a lack of renal metabolism precludes excessive formation of F- in kidney cells, and there is no evidence of nephrotoxicity in humans. Sevoflurane is not believed to be hepatotoxic because it is not broken down to yield the trifluoroacetyl halide metabolite. The cardiovascular effects induced by sevoflurane are somewhat similar to isoflurane. There is a decrease in alveolar ventilation similar to that observed with isoflurane. Therapeutic uses Sevoflurane has the advantages of a rapid onset, good control over the depth of anesthesia, and a rapid recovery, as previously noted for desflurane. One important advantage of sevoflurane over desflurane is that it is much less irritating to the respiratory tract, which, combined with its rapid induction and maintenance of heart rate, makes it suitable for inhalation induction of anesthesia in children. A potential drawback is that it breaks down in soda lime to compound A, greatly limiting its potential use in low-flow systems with conventional carbon dioxide absorbers. This problem can be circumvented by avoiding low gas flows (<2 L/min) or by using specific carbon dioxide absorbents without this characteristic. One other drawback is the potential for emergence agitation when used in pediatric patients. Therapeutic uses Despite its favorable blood/gas partition coefficient, desflurane is not indicated for the inhalation induction of anesthesia. When anesthesia has been achieved with other agents, desflurane may be administered for maintenance purposes. Desflurane then permits a more rapid control over the depth of anesthesia than other inhalation agents and a more rapid recovery, allowing for a more precise duration of general anesthesia. Historically, their primary role was as single-dose induction agents prior to maintenance of general anesthesia with inhalation agents. For this technique, the drugs are ideally administered by continuous infusion via a computer-controlled pump, with intermittent boluses as needed to adjust the anesthetic depth rapidly. For most intravenous anesthetics, the termination of effect depends largely on redistribution of the drug out of the brain. Metabolic inactivation generally assumes a more central role when the agent is administered over an extended period. With the exception of the benzodiazepines and dexmedetomidine, these drugs can easily induce anesthesia, at which time maintenance may be carried out by either inhalation agents or continued infusion of the intravenous drug. Suggested ideal properties for an intravenous anesthetic drug are listed in Box 15-3. Although short-acting and ultrashort-acting barbiturates were previously widely administered to produce all modes of anesthesia and sedation, drugs from other classes are now used more frequently. These Sevoflurane First synthesized in the United States in 1968, sevoflurane became widely used in Japan in 1990 and available for clinical use in the United States in 1995. A relatively pleasant odor, lack of airway irritation, and rapid onset of action make sevoflurane an attractive agent for inhalation induction of anesthesia in pediatrics. Physical and chemical properties Sevoflurane is characterized by a low blood/gas partition coefficient (0. Anesthetic properties As would be expected, the low solubility of sevoflurane results in rapid onset, recovery, and adjustment of anesthetic depth. The benefit of the low blood:gas solubility in regard to offset of anesthesia is counterbalanced in longer cases (>2 hours) where transfer into fat can occur. This same enzyme may also be largely responsible for the degradation of isoflurane and desflurane. Although it is more likely than thiopental to cause pain on intravenous injection, methohexital in a 1% concentration is much less damaging after intraarterial injection or extravasation into local tissues. Its primary advantage is the rapid recovery and lower cumulative effect compared with thiopental, making it more suitable for outpatient procedures. Methohexital also is much more stable when reconstituted with sterile water; a 1% solution can be stored at room temperature and used for 6 weeks (versus 1 week for thiopental when refrigerated).

References

• Rubin MA, Putzi M, Mucci N, et al: Rapid (iwarmi) autopsy study for procurement of metastatic prostate cancer, Clin Cancer Res 6(3):1038n1045, 2000.
• Easton JD, Saver JL, Albers GW, et al: Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists, Stroke 40:2276-2293, 2009.
• Tanaka K. Isovaleric acidemia: personal history clinical survey and study of the molecular basis. Prog Clin Biol Res 1990;321:273.
• Wilson BC, Cohn JN. Right ventricular infarction: clinical and pathophysiologic considerations. Adv Intern Med. 1988;33:295-309.
• Faurschou P. Thoracoscopy in rheumatoid pleural effusion. Pneumologie 1989;43(2):69-71.
• Koelbl H, Igawa T, Salvatore S, et al: Pathophysiology of urinary incontinence, fecal incontinence and pelvic organ prolapse. In Abrams P, Cardozo L, Khoury S, et al, editors: Incontinence, Paris, 2013, ICUD-EAU, pp 261n360. Krane R, Siroky M: Classification of voiding dysfunction: value of classification systems. In Barrett D, Wein A, editors: Controversies in neuro-urology, New York, 1984, Churchill Livingstone, pp 223n238. Lapides J: Neuromuscular, vesical and ureteral dysfunction. In Campbell M, Harrison J, editors: Urology, Philadelphia, 1970, Saunders, pp 1343n1379.